Delivery Order SPE2DB24D9224-SPE2DB25FJGFP
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,339.18 by the Defense Logistics Agency on July 21, 2025, for the supply of Xtandi 80 mg tablets (60-count units). This delivery order was issued without a set-aside designation and is scheduled for completion by July 22, 2025, with performance taking place at the contractor's Park Ridge facility. The award represents a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $4,169.59 by the Defense Logistics Agency on July 21, 2025, for the supply of Xtandi 80 mg tablets (60-count). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, and carries no set-aside designation. The place of performance is located in Park Ridge, Illinois, where the vendor...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $25,017.54 on July 21, 2025, for the supply of Xtandi 80 mg tablets (60-count units). The award was issued under a firm fixed-price contract type with no set-aside designation, reflecting the company's competitive standing in federal procurement markets. The funding agency is the Defense Logistics Agency's Medical Supply Chain division, and...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $8,339.18 by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Xtandi 80 mg tablets (60-count units). The contract is a firm fixed-price delivery order with an ultimate completion date of July 25, 2025, and carries no set-aside designation. This award was issued under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,622.72 by the Defense Logistics Agency on July 29, 2025. The contract calls for the delivery of Xtandi 40 mg capsules (120-count units) with an ultimate completion date of July 30, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $4,169.59 by the Defense Logistics Agency on August 5, 2025, for the supply of Xtandi 80 mg tablets (60-count units). The contract utilizes a firm fixed-price delivery order mechanism without a set-aside designation, with an ultimate completion date of August 6, 2025. This award represents a single delivery order executed under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,169.59 by the Defense Logistics Agency (DLA) on July 22, 2025. The contract, which carries no set-aside designation, calls for the delivery of 60 tablets of Xtandi 80 mg, an oncology medication used in cancer treatment. This delivery order represents one of many pharmaceutical supply orders issued under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $17,245.40 by the Defense Logistics Agency on August 13, 2025, for the supply of Xtandi 40 mg capsules (120-count units). The award carries no set-aside designation and is structured as a firm fixed-price delivery order with an ultimate completion date of August 14, 2025. This award is issued under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order from the Defense Logistics Agency (DLA) valued at $4,169.59 for 60 tablets of Xtandi 80 mg. The award, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a standard pharmaceutical supply delivery to support Department of Defense healthcare operations. This delivery order was issued without a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $8,339.18 by the Defense Logistics Agency on July 28, 2025, for the supply of Xtandi 80 mg tablets (60-count packages). This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, represents a specific product requisition under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The...
- SPE2DB24D9224Indefinite Delivery Contract
- SPE2DB24D9224-SPE2DB25FJGFPDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $4,169.59 on August 12, 2025, for the supply of Xtandi 80 mg tablets (60-count units). The Defense Logistics Agency issued this firm fixed-price delivery order under its larger Indefinite Delivery Contract with DMS Pharmaceutical Group, which is valued at $500 million and remains active through November 2026. The contract carries no set-aside designation, and the ultimate completion date is set for August 13, 2025. Place of performance is located in Park Ridge, Illinois. This delivery order represents a continuation of DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, particularly for the Department of Defense healthcare system. Xtandi is an oncology medication, consistent with the company's portfolio of specialized pharmaceutical products supplied to military health facilities nationwide. The award leverages the existing SPE2DB program indefinite delivery contract mechanism, which enables the Defense Logistics Agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, biologics, and medical consumables supporting Department of Defense medical supply requirements globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 8/12/25 |